Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2014, and provided an operating forecast and program updates.
Financial highlights for the first quarter of 2014 include (all comparisons are with the first quarter of 2013):
•Total revenues increased 37% to $16.0 million, and royalty revenues increased 35% to $7.9 million
Help employers find you! Check out all the jobs and post your resume.
